Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

Abstract

Data suggested that PD-L1 and PD-1 can be useful prognostic biomarkers for survival and can pave the way toward new immunotherapy regimens against PNETs through targeting the PD-L1/PD-1 pathway.